Skip to content
10-Q

Quarterly Report

FV Pharma International Corp.

0001565220-13-000008

← back to feed
Filed
Aug 29, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jul 31, 2013 8.36M sh
Operating Cash Flow Q2 2013 · Jul 31, 2013 −$18.42K
Operating Cash Flow Q2 2013 · Jul 31, 2013 −$16.66K
Total Liabilities Q2 2013 · Jul 31, 2013 $288
Total Liabilities Q2 2013 · Jan 31, 2013 $552
Current Assets Q2 2013 · Jul 31, 2013 $19.48K
Current Assets Q2 2013 · Jan 31, 2013 $31.56K
Total Assets Q2 2013 · Jul 31, 2013 $19.48K
Total Assets Q2 2013 · Jan 31, 2013 $31.56K
Eps Basic Q2 2013 · Jul 31, 2013 $0.00
Eps Basic Q2 2013 · Jul 31, 2013 $0.00
Sga Expense Q2 2013 · Jul 31, 2013 $12.8K
Net Income Q2 2013 · Jul 31, 2013 −$10.41K
Operating Income Q2 2013 · Jul 31, 2013 −$4.57K
Operating Income Q2 2013 · Jul 31, 2013 −$11.82K
Operating Income Q2 2013 · Jul 31, 2013 −$10.33K
Revenue Q2 2013 · Jul 31, 2013 $2.48K